Global Nucleic Acid Delivery System Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Nucleic Acid Delivery System Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Nucleic Acid Delivery System (NADS) refers to a range of technologies and methods that are used to deliver nucleic acids, such as DNA or RNA, into cells or tissues. In gene therapy and genetic engineering, NADS play a critical role in delivering therapeutic genes to target cells to treat genetic diseases, as well as in introducing new genetic traits into organisms for various purposes.
The delivery of nucleic acids into cells is challenging due to their large size, negative charge, and susceptibility to degradation by nucleases in the extracellular environment. NADS typically consist of a carrier molecule, such as a lipid or polymer, which can protect the nucleic acids and facilitate their entry into cells. Different types of NADS have been developed over the years, including viral vectors, non-viral vectors, and physical methods such as electroporation and sonoporation.
NADS have become increasingly important in biomedical research and clinical applications, and have shown promising results in treating a variety of genetic diseases, including cystic fibrosis, hemophilia, and muscular dystrophy. They also hold promise for the development of new therapies for cancer and other complex diseases.
Nucleic Acid Delivery System report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Nucleic Acid Delivery System market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Drug Development and Gene Therapy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Nucleic Acid Delivery System industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Nucleic Acid Delivery System key companies include Creative Biogene, Evonik Health Care, Factor Bioscience, Polyplus and AccuRna, etc. Creative Biogene, Evonik Health Care, Factor Bioscience are top 3 players and held % share in total in 2022.
Nucleic Acid Delivery System can be divided into Viral Vectors, Lipid-based Carriers and Protein-based Carriers,, etc. Viral Vectors is the mainstream product in the market, accounting for % share globally in 2022.
Nucleic Acid Delivery System is widely used in various fields, such as Drug Development, Gene Therapy, Biopharmaceuticals and Scientific Research, etc. Drug Development provides greatest supports to the Nucleic Acid Delivery System industry development. In 2022, global % share of Nucleic Acid Delivery System went into Drug Development filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Nucleic Acid Delivery System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Vector, Application and Regions Listed in the Report
Creative Biogene
Evonik Health Care
Factor Bioscience
Polyplus
AccuRna
Segment by Vector
Viral Vectors
Lipid-based Carriers
Protein-based Carriers
Drug Development
Gene Therapy
Biopharmaceuticals
Scientific Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Nucleic Acid Delivery System market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Vectors and Revenue analysis of Each Vector in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Nucleic Acid Delivery System introduction, etc. Nucleic Acid Delivery System Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Nucleic Acid Delivery System market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
The delivery of nucleic acids into cells is challenging due to their large size, negative charge, and susceptibility to degradation by nucleases in the extracellular environment. NADS typically consist of a carrier molecule, such as a lipid or polymer, which can protect the nucleic acids and facilitate their entry into cells. Different types of NADS have been developed over the years, including viral vectors, non-viral vectors, and physical methods such as electroporation and sonoporation.
NADS have become increasingly important in biomedical research and clinical applications, and have shown promising results in treating a variety of genetic diseases, including cystic fibrosis, hemophilia, and muscular dystrophy. They also hold promise for the development of new therapies for cancer and other complex diseases.
Nucleic Acid Delivery System report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Nucleic Acid Delivery System market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Drug Development and Gene Therapy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Nucleic Acid Delivery System industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Nucleic Acid Delivery System key companies include Creative Biogene, Evonik Health Care, Factor Bioscience, Polyplus and AccuRna, etc. Creative Biogene, Evonik Health Care, Factor Bioscience are top 3 players and held % share in total in 2022.
Nucleic Acid Delivery System can be divided into Viral Vectors, Lipid-based Carriers and Protein-based Carriers,, etc. Viral Vectors is the mainstream product in the market, accounting for % share globally in 2022.
Nucleic Acid Delivery System is widely used in various fields, such as Drug Development, Gene Therapy, Biopharmaceuticals and Scientific Research, etc. Drug Development provides greatest supports to the Nucleic Acid Delivery System industry development. In 2022, global % share of Nucleic Acid Delivery System went into Drug Development filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Nucleic Acid Delivery System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Vector, Application and Regions Listed in the Report
By Company
Creative Biogene
Evonik Health Care
Factor Bioscience
Polyplus
AccuRna
Segment by Vector
Viral Vectors
Lipid-based Carriers
Protein-based Carriers
Segment by Application
Drug Development
Gene Therapy
Biopharmaceuticals
Scientific Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Nucleic Acid Delivery System market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Vectors and Revenue analysis of Each Vector in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Nucleic Acid Delivery System introduction, etc. Nucleic Acid Delivery System Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Nucleic Acid Delivery System market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices